Interv Akut Kardiol. 2010;9(4):195-197

Biodegradable coronary stents

Martin Mates
Kardiologické oddělení –, Komplexní kardiovaskulární centrum, Nemocnice Na Homolce, Praha

Biodegradable coronary stents are manufactured from a material, which is completely absorbed in months to years after implantation.

In theory there are several advantages related to biodegradable stents, although clinical experience is very limited at the moment. This

article gives a review of used technologies, results of clinical trials and explain possible advantages of bioabsorbable stents.

Keywords: coronary stent, medication stent, biodegradability

Published: October 15, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mates M. Biodegradable coronary stents. Interv Akut Kardiol. 2010;9(4):195-197.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Serruys PW, de Jaegere P, Kiemeneij F, et al. for the Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495. Go to original source... Go to PubMed...
    2. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987; 316: 701-706. Go to original source... Go to PubMed...
    3. Moses JW, Leon MB, Popma JJ, et al, for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323. Go to original source... Go to PubMed...
    4. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing. J Am Coll Cardiol 2006; 48: 193-202. Go to original source... Go to PubMed...
    5. Serruys PW, Daemen J. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation 2007; 115: 1433e9. Go to original source... Go to PubMed...
    6. Jeremias A, Kirtane A. Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention. Ann Intern Med 2008; 148: 234e8. Go to original source... Go to PubMed...
    7. Ludman P. BCIS Audit Returns Adult Interventional Procedures Jan 2008eDec 2008. http://www.bcis.org.uk/resources/audit/audit2008
    8. Kimura T, Kaburagi S, Tamura T, et al. Remodeling responses of human coronary arteries undergoing coronary angioplasty and atherectomy. Circulation. 1997; 96: 475-483. Go to original source... Go to PubMed...
    9. Di Mario C, Gil R, Camenzind E, et al. Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy. Am J Cardiol. 1995; 75: 772-777. Go to original source... Go to PubMed...
    10. Luo H, Nishioka T, Eigler N, et al. Coronary artery restenosis after balloon angioplasty in humans is associated with circumferential coronary constriction. Arterioscler Thromb Vasc Biol. 1966; 16: 1393-1398. Go to original source... Go to PubMed...
    11. Tamai H, Igaki K, Kyo E, et al. Initial and 6-month results of biodegradable poly-L-lactic acid coronary stents in humans. Circulation. 2000; 102: 399-404. Go to original source... Go to PubMed...
    12. Ormiston J, Serruys PW, Regar E, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet. 2008; 371: 899-907. Go to original source... Go to PubMed...
    13. Serruys PW, Ormiston J, Onuma Y, et al. Absorb trial first-inman evaluation of a bioabsorbable everolimus-eluting coronary stent system: two-year outcomes and results from multiple imaging modalities. Lancet. 2009; 373: 897-910. Go to original source... Go to PubMed...
    14. Erbel R, Di Mario C, Bartunek J, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomized multicentre trial. Lancet. 2007; 369: 1869-1875. Go to original source... Go to PubMed...
    15. Ormiston J, Serruys PW. Bioabsorbable Coronary Stents. Circ Cardiovasc Interv 2009; 2; 255-260. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.